picropodophyllin has been researched along with Cancer of Nasopharynx in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Guo, W; Tao, ZZ; Yin, SC | 1 |
1 other study(ies) available for picropodophyllin and Cancer of Nasopharynx
Article | Year |
---|---|
Picropodophyllin inhibits tumor growth of human nasopharyngeal carcinoma in a mouse model.
Topics: Animals; Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Inhibitory Concentration 50; Mice; Mice, Inbred BALB C; Mice, Nude; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Neoplasm Metastasis; Phosphorylation; Podophyllotoxin; Proto-Oncogene Proteins c-akt; Receptor, IGF Type 1; Somatomedins; Xenograft Model Antitumor Assays | 2013 |